Noopept (Omberacetam) – Solution, 600mg (20mg/mL)

Noopept (Omberacetam) – Solution, 600mg (20mg/mL)

This premium laboratory-grade research dipeptide compound is supplied as a ready-to-use aqueous solution engineered for modern scientific investigations requiring precise racetam-derived dipeptide pharmacology and cognitive/neuroprotection research. Noopept (Omberacetam, GVS-111, DVD-111, SGS-111, N-phenylacetyl-L-prolylglycine ethyl ester) is a synthetic dipeptide compound derived from the racetam family, structurally related to piracetam analogs, with cognitive-enhancing, neuroprotective, high affinity for AMPA and NMDA receptors (involved in synaptic signaling and enzymatic regulation), GABA-modulating, and prodrug of cyclic glycine-proline properties that interacts with glutamatergic and cholinergic pathways, exhibits neuroprotective effects decreasing extent of necrotic damage caused by photoinduced thrombosis of cortical blood vessels in brain injuries and stroke, protects PC12 cells against deleterious actions of Aβ (beta-amyloid) through inhibiting oxidative damage and calcium overload in Alzheimer’s disease research, reduces anxiety and stress levels providing calming effect that can enhance overall mental performance, enhances memory, learning, and focus making it popular among students and professionals seeking mental clarity, provides significant neuroprotection beneficial in conditions like Alzheimer’s and other neurodegenerative diseases, shows both stimulant and anti-anxiety properties, is orally available, frequently dosed at 10–30 mg per day in humans although no solid evidence indicating optimal dose with few human trials carried out, animal studies have used doses ranging from 0.1 mg/kg bodyweight to 10 mg/kg bodyweight, making it a valuable tool for in vitro/in vivo modeling of cognitive enhancement, neuroprotection, neurodegenerative diseases, Alzheimer’s disease, brain injuries, stroke, anxiety reduction, stress reduction, glutamatergic/cholinergic pathway modulation, AMPA/NMDA receptor function, and GABA modulation research.

All domestic orders ship directly from primary United States production facilities, ensuring rapid delivery to all 50 U.S. states. International orders to the UK and continental Europe are fulfilled through our dedicated United Kingdom shipping hub, enabling seamless, efficient customs clearance across European borders without delay.

• Batch-coded containers with publicly accessible third-party lab reports verifying specification consistency for absolute transparency; endotoxin-free

• Formulation completely free of adulterants, excipients, and stabilizers to guarantee raw dipeptide purity in solution; endotoxin-free product

• Packaging engineering utilizes a glass bottle with UV resistance and tamper-proof seal to maintain solution stability during transit and room temperature storage below 25°C

• Includes graduated pipette for convenient measurement; less than 10% variance in concentration guarantees consistency

Technical Specifications & Chemical Profile

Research Applications & Storage Protocols

Racetam-Derived Dipeptide with AMPA/NMDA Modulation and Neuroprotective Profile

Noopept functions as a synthetic dipeptide compound derived from the racetam family, structurally related to piracetam analogs, with high affinity for AMPA and NMDA receptors involved in synaptic signaling and enzymatic regulation, and is a prodrug of cyclic glycine-proline serving as AMPA receptor modulator potentially for treatment of cognitive deficits. The compound demonstrates cognitive enhancer enhancing memory, learning, and focus making it popular among students and professionals seeking mental clarity, exhibits neuroprotective effects beneficial in conditions like Alzheimer’s and other neurodegenerative diseases, provides significant neuroprotection, decreases extent of necrotic damage caused by photoinduced thrombosis of cortical blood vessels, protects PC12 cell against deleterious actions of Aβ (beta-amyloid) through inhibiting oxidative damage and calcium overload in Alzheimer’s disease research evidence, interacts with glutamatergic pathways and cholinergic pathways, has GABA-modulating properties, reduces anxiety and stress levels providing calming effect that can enhance overall mental performance, shows both stimulant and anti-anxiety properties, is orally available, frequently dosed at 10–30 mg per day in humans (no solid evidence indicating optimal dose, few human trials carried out), animal studies use doses ranging from 0.1 mg/kg bodyweight to 10 mg/kg bodyweight, has very short half-life but evidence in several mouse models suggests neuroprotective effect, making it valuable for investigators studying cognitive enhancement, neuroprotection, neurodegenerative diseases, Alzheimer’s disease, brain injuries, stroke, anxiety reduction, stress reduction, glutamatergic/cholinergic pathway modulation, AMPA/NMDA receptor function, GABA modulation, and racetam-derived dipeptide pharmacology in in vitro and in vivo experimental models.

Handling & Storage Guidelines

• Long-Term Storage: Store at room temperature below 25°C, tightly sealed, away from heat, light and moisture; avoid exposure to sun; glass bottle provides UV protection; solution requires storage below 25°C to remain stable; solutions can be stored at -20°C for up to 1 month; shelf life up to 12 months

• Solubility: Supplied pre-dissolved in deionized water Type II at 20mg/mL; soluble in DMSO up to 25 mg/ml; soluble in aqueous solution; clear liquid appearance

• Pipette Measurement: Graduated pipette included for convenient measurement; less than 10% variance guarantees consistency

Legal Status & Regulatory Information

• Australia: S4 (Prescription only)

• United States: Unapproved “New Drug” (21 U.S. Code § 321(p)(1)); Use in dietary supplements, food, or medicine is unlawful; otherwise uncontrolled

• Hungary: As of 25 August 2020, added to controlled psychoactive substances list, prohibiting production, sale, import, storage and use

• Russia: Drug of medicine, available without prescription

• United Kingdom: Not illegal to produce, supply, or import under Psychoactive Substance Act (came into effect May 26, 2016) because it neither works as CNS depressant nor CNS stimulant; however, sale and supply for human consumption are prohibited

Global Logistics & Order Fulfillment

We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.

Laboratory Use Only Disclaimer

This material is classified as a chemical reagent/reference material approved for marketing in the European Union, and can only be used for laboratory scientific research. The product is not a drug, food product or dietary supplement. This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. Not for use in diagnostic, therapeutic or cosmetic procedures. Not for human or animal consumption. Always consult with a healthcare professional before starting any new supplement or research product. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.